Taken together, these findings emphasize the critical role of JAK1/2-mediated cytokine signaling—especially IL-6 and IL-15–STAT3—in elevating activation phenotypes across T cells and myeloid cells in SLE. Here, STAT3 is linked to systemic lupus erythematosus.